Search for: "CF-3" Results 1901 - 1920 of 2,385
Sort by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
14 Feb 2011, 3:01 pm by Oliver G. Randl
On the contrary, the admissibility of a late filed request is always a matter of the board’s discretion (cf. inter alia T 446/00 [3.3]). [read post]
10 Feb 2011, 3:01 pm by Oliver G. Randl
T 641/00 [headnote 1] and G 3/08 [12.2.1-2]).[9.1] The calculation of the modular inverse according to claim 1 is not carried out with one of the conventional calculation methods mentioned in the description, which are based on the Euclidean algorithm […].[9.2] The Board has no indication justifying the assumption that the claimed method is notoriously known or indisputably forms part of the common general knowledge (cf. [read post]
2 Feb 2011, 2:51 pm by Falk Metzler
The proposed European and EU Patents Court (EEUPC) thus is absolutely required as institutional basis of the EU patent system (cf. [read post]
29 Jan 2011, 6:36 am by Mandelman
So, the lower court dismissed her frivolous claim, but what do you know… it must be a brand new day in the California courts because the Second District Appeals Court picked it right back up and, even though they declined to reverse the foreclosure, this past Thursday the court ruled 3-0 that… “… a lender who falsely promises to help a homeowner prevent foreclosure can be sued for fraud. [read post]
28 Jan 2011, 8:53 am by Dave
Yemshaw v Hounslow LBC [2011] UKSC 3 While my NL colleagues are off partying at a secret location for lunch, I’ve managed to steal a few precious minutes from an appallingly tight deadline (Sinead: if you’re reading this, it’ll be there, honest) to write a paean of praise in honour of Baroness Hale’s judgment in this case. [read post]
27 Jan 2011, 5:00 am by Bexis
  The answer, evident from the face of the complaint is (to us) no:[Plaintiff] proceeded on the theory that [defendant] failed to comply with the FDA’s MDR regulations requiring a manufacturer of a Class III device to report incidents.2011 WL 184554, at *3. [read post]
25 Jan 2011, 3:51 am by INFORRM
Compared to that, the social utility or value to be attached to identification, as such, is relatively low: cf. [read post]
24 Jan 2011, 3:01 pm by Oliver G. Randl
The example is carried out by following a study design wherein the antigens, the viral vector and the inoculation protocol are clearly defined (see point [3] above). [read post]